The global graft versus host disease (GvHD) treatment market size was valued at USD 2.8 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2030. The rise in the elderly population and an increase in the occurrence of nephrological, leukem... Read More »
February 2024The global triamcinolone ointment chlorofluorocarbons market size is expected to grow at a Compound Annual Growth Rate (CAGR) of 1.6% from 2024 to 2030. Triamcinolone ointment, a topical corticosteroid, plays a vital role in treating various skin conditions like eczema, psoriasis, and de... Read More »
February 2024The global over the counter (OTC) drugs market size was estimated at USD 189.3 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.92 from 2024- 2030. The growth can be attributed to factors such as increasing consumer willingness to spend on OTC medication, growing consumer awarene... Read More »
February 2024The global ulcerative colitis market size was valued at USD 636.98 million in 2023 and is expected to grow at a CAGR of 6.43% during the forecast period 2024-2030. One of the key driving factors attributed to the growth of the ulcerative colitis market is the increasing prevalence of the... Read More »
February 2024The global tinea pedis treatment market was valued at USD 1.3 billion in 2023 and is expected to grow at a CAGR of 7.09 % from 2024-2030. The market is experiencing growth due to the increasing prevalence of fungal foot infections globally, changing lifestyles, rising awareness about the... Read More »
February 2024The global ibuprofen API market size was valued at USD 700.8 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 1.17% from 2024 to 2030. The evolving API scenario in emerging economies, the increase in pharmaceutical and biopharmaceutical production, and t... Read More »
February 2024The global vitamin D therapy market size was valued at USD 2.04 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.06% from 2024 to 2030. The vitamin D therapy market is being driven by the growing awareness of the health benefits associated with vitamin... Read More »
February 2024The global methicillin-resistant staphylococcus aureus drugs market was valued at USD 2.15 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.51% from 2024 to 2030. This can be attributed to the pipeline space, and major pharmaceutical firms are advancin... Read More »
February 2024The global trachoma treatment market size was valued at USD 514.6 million in 2023 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.09% from 2024 to 2030. The market is experiencing growth due to the increasing incidence and prevalence of trachoma infectious disease. F... Read More »
February 2024The global influenza medications market size was valued at USD 928.9 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.09% from 2024-2030. The increasing incidence of influenza is set to drive the global demand for influenza medications. The growing ger... Read More »
February 2024The global anorexiants market size was valued around USD 900 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.77% from 2024 to 2030. Anorexiants, also known as appetite suppressants or weight loss medications, are drugs or pharmaceutical compounds spec... Read More »
February 2024The global oxytocin market is expected to grow at a CAGR of 6.1% from 2024 to 2030. Major factors contributing to the market growth include a rising incidence of pregnancy complications, a global increase in childbirth rates, and a growing awareness of induced labor and breastfeeding. Fo... Read More »
February 2024The global dacryocystitis market size expected to grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2030. The increasing prevalence of eye infections and technological advancements, growing clinical research, and subsequent new product launches boost the market growth. Fu... Read More »
February 2024The global compound camphor ointment market size was valued at USD 2.55 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.15% from 2024 to 2030. Compound camphor ointment acts as an analgesic and is used for chest congestion caused by cold & itching... Read More »
February 2024The global oncolytic virotherapy market was valued at USD 20.6 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 26.4% from 2024 to 2030. The rising prevalence of cancer and growing demand for gene therapy are the major factors driving the market for onco... Read More »
February 2024The global infectious enteritis treatment market size was valued at USD 453.46 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.09% from 2024 to 2030. The enduringly high prevalence of infectious enteritis, including conditions such as gastroenteritis ... Read More »
February 2024The U.S. minor cannabinoids market size was estimated at USD 11.5 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 15.0% from 2024 to 2030. Consumers have access to a wide range of products containing minor cannabinoids, which cater to their specific hea... Read More »
January 2024The global asthma therapeutics market size was valued at USD 26.4 billion in 2023 and is projected to grow from USD 30.6 billion in 2026 to USD 37.9 billion by 2030, at a CAGR of 5.3% from 2024 to 2030. The market in North America dominated with a revenue share of 50.2% in 2023. The glob... Read More »
January 2024The global biomarkers market size was estimated at USD 81.04 billion in 2023 and is projected to reach USD 194.21 billion by 2030, growing at a CAGR of 13.36% from 2024 to 2030. The rising prevalence of cancer, significance of companion diagnostics, i... Read More »
January 2024The global mineral supplements market size was estimated at USD 16.08 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2030. The growing adoption of mineral supplements to manage chronic conditions cancer, osteoporosis, anemia, and osteoporosis is anticipated to dr... Read More »
January 2024